{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:32Z","timestamp":1793387252845,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome, UCL\/UCLH NIHR Biomedical Research Centre (BRC) and Francis Crick Institute","award":["110110Z\/15\/Z"],"award-info":[{"award-number":["110110Z\/15\/Z"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["BST00070"],"award-info":[{"award-number":["BST00070"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Henry Dale Fellowship jointly funded by the Royal Society and Wellcome","award":["220171\/Z\/20\/Z"],"award-info":[{"award-number":["220171\/Z\/20\/Z"]}]},{"name":"GlaxoSmithKline (GSK) and the University of Oxford Nuffield Department of Medicine"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>The aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data from individual countries and little viral sequencing data available to represent the continent. We undertook a systematic review of the prevalence and genetic data available for hepatitis B virus (HBV) in Kenya using the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 checklist. We identified 23 studies reporting HBV prevalence and 8 studies that included HBV genetic data published in English between January 2000 and December 2021. We assessed study quality using the Joanna Briggs Institute critical appraisal checklist. Due to study heterogeneity, we divided the studies to represent low, moderate, high and very high-risk for HBV infection, identifying 8, 7, 5 and 3 studies in these groups, respectively. We calculated pooled HBV prevalence within each group and evaluated available sequencing data. Pooled HBV prevalence was 3.4% (95% CI 2.7\u20134.2%), 6.1% (95% CI 5.1\u20137.4%), 6.2% (95% CI 4.64\u20138.2) and 29.2% (95% CI 12.2\u201355.1), respectively. Study quality was overall low; only three studies detailed sample size calculation and 17\/23 studies were cross sectional. Eight studies included genetic information on HBV, with two undertaking whole genome sequencing. Genotype A accounted for 92% of infections. Other genotypes included genotype D (6%), D\/E recombinants (1%) or mixed populations (1%). Drug resistance mutations were reported by two studies. There is an urgent need for more high quality seroprevalence and genetic data to represent HBV in Kenya to underpin improved HBV screening, treatment and prevention in order to support progress towards elimination targets.<\/jats:p>","DOI":"10.1371\/journal.pgph.0001165","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T13:23:43Z","timestamp":1675171423000},"page":"e0001165","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy"],"prefix":"10.1371","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-4704","authenticated-orcid":true,"given":"Louise O.","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cori","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1991-9992","authenticated-orcid":true,"given":"Paul","family":"Yonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Githinji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2790-8353","authenticated-orcid":true,"given":"M. Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":true,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony O.","family":"Etyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"pgph.0001165.ref001","unstructured":"World Health Organisation. Global hepatitis report, 2017 [Internet]. 2017 [cited 2021 Nov 10]. https:\/\/www.who.int\/publications\/i\/item\/global-hepatitis-report-2017"},{"issue":"10","key":"pgph.0001165.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005842","article-title":"Hepatitis B virus infection as a neglected tropical disease","volume":"11","author":"GA O\u2019Hara","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pgph.0001165.ref003","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016\u20132021. Global Hepatitis Programme Department of HIV\/AIDS [Internet]. 2016 [cited 2021 Nov 9];(June):56. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"pgph.0001165.ref004","unstructured":"Countries Dashboard\u2013CDA Foundation [Internet]. [cited 2022 Feb 7]. https:\/\/cdafound.org\/polaris-countries-dashboard\/"},{"key":"pgph.0001165.ref005","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2019.34.31.17885","article-title":"Prevalence and associated risk factors of transfusion transmissible infections among blood donors at regional blood transfusion center nakuru and tenwek mission hospital, Kenya","volume":"34","author":"G Bartonjo","year":"2019","journal-title":"Pan African Medical Journal"},{"issue":"12","key":"pgph.0001165.ref006","first-page":"626","article-title":"HBV, HIV co-infection at Kisumu District Hospital, Kenya","volume":"81","author":"AEO Otedo","year":"2004","journal-title":"East Afr Med J"},{"issue":"3","key":"pgph.0001165.ref007","article-title":"Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy","volume":"8","author":"SL Day","year":"2013","journal-title":"PLoS One"},{"key":"pgph.0001165.ref008","volume-title":"Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020","author":"HM Kafeero","year":"2021"},{"key":"pgph.0001165.ref009","unstructured":"Ministry of Health. Kenya, National Policy Guidelines on Immunization 2013. 2013. 20 p."},{"key":"pgph.0001165.ref010","unstructured":"Triple elimination initiative of mother-to-child transmission of HIV, syphilis and hepatitis B [Internet]. [cited 2022 Sep 12]. https:\/\/www.who.int\/initiatives\/triple-elimination-initiative-of-mother-to-child-transmission-of-hiv-syphilis-and-hepatitis-b"},{"key":"pgph.0001165.ref011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1099\/jgv.0.001387","article-title":"Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences","volume":"101","author":"AL Mcnaughton","year":"2020","journal-title":"Journal of General Virology"},{"issue":"2","key":"pgph.0001165.ref012","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2018.07.058","article-title":"Insights From Deep Sequencing of the HBV Genome\u2014Unique, Tiny, and Misunderstood","volume":"156","author":"AL McNaughton","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"pgph.0001165.ref013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.26635","article-title":"Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults","volume":"59","author":"K Ito","year":"2014","journal-title":"Hepatology"},{"key":"pgph.0001165.ref014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","article-title":"The clinical implications of hepatitis B virus genotype: Recent advances [Internet]","volume":"26","author":"CL Lin","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology (Australia). John Wiley & Sons, Ltd"},{"issue":"2","key":"pgph.0001165.ref015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"P Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"pgph.0001165.ref016","unstructured":"PRISMA 2020 Checklist Section and Topic Item # Checklist item Location where item is reported TITLE Title 1 Identify the report as a systematic review. [cited 2022 Feb 16]; http:\/\/www.prisma-statement.org\/"},{"key":"pgph.0001165.ref017","unstructured":"critical-appraisal-tools\u2014Critical Appraisal Tools | Joanna Briggs Institute [Internet]. [cited 2022 Feb 9]. https:\/\/jbi.global\/critical-appraisal-tools"},{"issue":"4","key":"pgph.0001165.ref018","first-page":"1160","volume":"20","author":"K Katoh","year":"2019","journal-title":"MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization"},{"key":"pgph.0001165.ref019","article-title":"NGPhylogeny.fr: new generation phylogenetic services for non-specialists","volume":"47","author":"F Fr","year":"2019","journal-title":"Web Server issue Published online"},{"issue":"1","key":"pgph.0001165.ref020","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01447-2","article-title":"Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya","volume":"17","author":"PO Aluora","year":"2020","journal-title":"Virol J"},{"key":"pgph.0001165.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244947","article-title":"Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy na\u00efve adults","volume":"16","author":"A Salyani","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"pgph.0001165.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233727","article-title":"Characterization of occult hepatitis B in highrisk populations in Kenya","volume":"15","author":"KB Jepkemei","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"pgph.0001165.ref023","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11262-013-0976-1","article-title":"Hepatitis B virus subgenotype A1, occurrence of subgenotype D4, and S gene mutations among voluntary blood donors in Kenya","volume":"47","author":"SO Kwange","year":"2013","journal-title":"Virus Genes"},{"key":"pgph.0001165.ref024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.meegid.2013.08.013","article-title":"Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya","volume":"20","author":"M Ochwoto","year":"2013","journal-title":"Infection, Genetics and Evolution"},{"issue":"4","key":"pgph.0001165.ref025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/QAI.0000000000001511","article-title":"Comparison of hepatitis b virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052","volume":"76","author":"AE Greer","year":"2017","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"issue":"4","key":"pgph.0001165.ref026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4314\/eamj.v81i4.9152","article-title":"Prevalence of hepatitis A, B, C and human immunodeficiency virus seropositivity among patients with acute icteric hepatitis at the Kenyatta National Hospital, Nairobi","volume":"81","author":"JO Atina","year":"2004","journal-title":"East Afr Med J"},{"issue":"6","key":"pgph.0001165.ref027","first-page":"199","article-title":"Seroprevalence of HAV, HBV, HCV, and HEV among acute hepatitis patients at Kenyatta National Hospital in Nairobi, Kenya","volume":"89","author":"I Muchiri","year":"2013","journal-title":"East Afr Med J"},{"issue":"1","key":"pgph.0001165.ref028","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1409-2","article-title":"Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya","volume":"16","author":"M Ochwoto","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pgph.0001165.ref029","first-page":"1","article-title":"Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya","volume":"15","author":"MW Kilongosi","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pgph.0001165.ref030","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw253","article-title":"Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya","volume":"4","author":"E Wahome","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"pgph.0001165.ref031","doi-asserted-by":"crossref","DOI":"10.4102\/sajhivmed.v19i1.737","article-title":"Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities","volume":"19","author":"M Oyaro","year":"2018","journal-title":"South Afr J HIV Med"},{"issue":"10","key":"pgph.0001165.ref032","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/QAD.0b013e32830162a8","article-title":"HIV, hepatitis B and hepatitis C coinfection in Kenya","volume":"22","author":"RS Harania","year":"2008","journal-title":"AIDS"},{"issue":"10","key":"pgph.0001165.ref033","article-title":"HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya","volume":"18","author":"HN Kim","year":"2011","journal-title":"J Viral Hepat"},{"issue":"1","key":"pgph.0001165.ref034","first-page":"1","article-title":"Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes","volume":"6","author":"BM Muriuki","year":"2013","journal-title":"Internet]"},{"issue":"10","key":"pgph.0001165.ref035","first-page":"488","article-title":"Prevalence and risk factors of previous or active Hepatitis B infection among HIV-1 discordant heterosexual couples","volume":"92","author":"EN Njuguna","year":"2015","journal-title":"East Afr Med J"},{"issue":"12","key":"pgph.0001165.ref036","first-page":"640","article-title":"Genotypes of HBV and HCV among HIV-1 co-infected individuals in Ngong Sub-County, Kenya","volume":"93","author":"D Maina","year":"2017","journal-title":"East Afr Med J"},{"key":"pgph.0001165.ref037","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2016.24.315.9255","article-title":"Prevalence, awareness and risk factors associated with hepatitis b infection among pregnant women attending the antenatal clinic at mbagathi district hospital in Nairobi, Kenya","volume":"24","author":"JA Malungu Ngaira","year":"2016","journal-title":"Pan African Medical Journal"},{"issue":"2","key":"pgph.0001165.ref038","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4269\/ajtmh.16-0059","article-title":"Prevalence of hepatitis B Virus infection in Kenya, 2007","volume":"95","author":"KN Ly","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"pgph.0001165.ref039","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/labmed\/lmx059","article-title":"Transfusion transmissible infections among walk-in blood donors at Kisumu regional blood transfusion centre, Kisumu County, Kenya, 2015","volume":"48","author":"D Wamamba","year":"2017","journal-title":"Lab Medicine"},{"issue":"1","key":"pgph.0001165.ref040","article-title":"Seroprevalence and determinants of transfusion transmissible infections among voluntary blood donors in Homabay, Kisumu and Siaya counties in western Kenya","volume":"11","author":"CG Onyango","year":"2018","journal-title":"BMC Res Notes"},{"issue":"4","key":"pgph.0001165.ref041","first-page":"765","article-title":"Prevalence of hepatitis B virus infection and uptake of hepatitis B vaccine among healthcare workers, Makueni County, Kenya 2017","volume":"41","author":"EN Kisangau","year":"2019","journal-title":"Journal of Public Health (United Kingdom)"},{"key":"pgph.0001165.ref042","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8578172","article-title":"Seroprevalence and Risk Factors for Hepatitis B Virus Infection in Adolescent Blood Donors within Selected Counties of Western Kenya","volume":"2020","author":"HO Awili","year":"2020","journal-title":"Biomed Res Int"},{"key":"pgph.0001165.ref043","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/jcp.32.11.1180","article-title":"A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs","volume":"32","author":"JAJ Barbara","year":"1979","journal-title":"J Clin Pathol"},{"issue":"6","key":"pgph.0001165.ref044","first-page":"1281","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B","volume":"67","author":"N Rajoriya","year":"2017","journal-title":"Time for an individualised approach?"},{"issue":"4","key":"pgph.0001165.ref045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1570162X13666150121113217","article-title":"Characterization of HBV Among HBV\/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya","volume":"13","author":"R Kibaya","year":"2015","journal-title":"Curr HIV Res"},{"issue":"Pt 2","key":"pgph.0001165.ref046","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1099\/vir.0.012740-0","article-title":"Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication","volume":"91","author":"C Wu","year":"2010","journal-title":"J Gen Virol"},{"issue":"9","key":"pgph.0001165.ref047","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/JCM.00508-07","article-title":"The Amino Acid Residues at Positions 120 to 123 Are Crucial for the Antigenicity of Hepatitis B Surface Antigen","volume":"45","author":"Y Tian","year":"2007","journal-title":"J Clin Microbiol"},{"key":"pgph.0001165.ref048","unstructured":"Downs L, Campbell C, Githinji G, Ansari A, Matthews P, Etyang AO. Treatment Eligibility Criteria Assessment in Hepatitis B Virus (HBV) Prevalence Studies in Kenya. 2022 Sep 12 [cited 2022 Sep 12]; \/articles\/journal_contribution\/Treatment_Eligibility_Criteria_Assessment_in_Hepatitis_B_Virus_HBV_Prevalence_Studies_in_Kenya_\/21063880\/2"},{"key":"pgph.0001165.ref049","unstructured":"CDC Global Health\u2014Kenya\u2014Blog: Giving Blood, Giving Life [Internet]. [cited 2022 Feb 8]. https:\/\/www.cdc.gov\/globalhealth\/countries\/kenya\/blog\/giving.htm"},{"issue":"1","key":"pgph.0001165.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-11164-2","article-title":"Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment","volume":"21","author":"J Tunnage","year":"2021","journal-title":"BMC Public Health"},{"key":"pgph.0001165.ref051","unstructured":"Nosocomial Outbreak of Hepatitis B Virus Infection in a Pediatric Hematology and Oncology Unit in South Africa: Epidemiological Investigation and Measures to Prevent Further Transmission. 2015;"},{"issue":"11","key":"pgph.0001165.ref052","doi-asserted-by":"crossref","first-page":"e1600","DOI":"10.1016\/S2214-109X(21)00304-1","article-title":"Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study","volume":"9","author":"P Thompson","year":"2021","journal-title":"Lancet Glob Health"},{"key":"pgph.0001165.ref053","author":"M Abdulkadir Hassan-Kadle","journal-title":"Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study"},{"key":"pgph.0001165.ref054","article-title":"Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan","volume":"26","author":"ALS Kirbak","year":"2017","journal-title":"Pan Afr Med J"},{"key":"pgph.0001165.ref055","unstructured":"2019 Kenya Population and Housing Census Volume I: Population by County and Sub-County\u2014Kenya National Bureau of Statistics [Internet]. [cited 2022 Mar 15]. https:\/\/www.knbs.or.ke\/?wpdmpro=2019-kenya-population-and-housing-census-volume-i-population-by-county-and-sub-county"},{"key":"pgph.0001165.ref056","unstructured":"Kenya | UNAIDS [Internet]. [cited 2022 Feb 22]. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/kenya"},{"key":"pgph.0001165.ref057","unstructured":"eEML\u2014Electronic Essential Medicines List [Internet]. [cited 2022 Feb 22]. https:\/\/list.essentialmeds.org\/?query=tenofovir%20disoproxil%20fumarate"},{"key":"pgph.0001165.ref058","unstructured":"Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) [Internet]. [cited 2022 Feb 16]. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/hepatitis-b-(hepb3)-immunization-coverage-among-1-year-olds-(-)"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0001165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T13:24:50Z","timestamp":1675171490000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0001165"}},"subtitle":[],"editor":[{"given":"Abraham D.","family":"Flaxman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0001165","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.08.22273611","asserted-by":"object"}]},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}